# Letrozole Treatment in Normal and GnRH Deficient Women

> **NCT00351416** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Massachusetts General Hospital** · enrollment: 15 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Letrozole
- **DRUG:** NAL-GLU GnRH antagonist

## Key facts

- **NCT ID:** NCT00351416
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-01-21
- **Primary completion:** 2009-06-29
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00351416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00351416, "Letrozole Treatment in Normal and GnRH Deficient Women". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00351416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*